BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Cytheris SA 

Technopolis
175, rue Jean-Jacques Rousseau
Issy-les-Moulineaux    92130  France
Phone: 33-0-1-5888-3800 Fax: 33-0-1-4644-4446


SEARCH JOBS








 Company News
Cytheris SA Announces U.S. Orphan Drug Designation for CYT107 for the Treatment of Progressive Multifocal Leucoencephalopathy (PML) 10/24/2012 10:19:46 AM    More...
Cytheris SA Announces Publication in Blood Demonstrating CYT107 Reverses Lymphopenia and Increases Virus-Specific Immunity Post Stem Cell Transplantation 10/9/2012 12:03:48 PM    More...
Cytheris SA Announces CYT107 Orphan Drug Designation in Europe for the Treatment of Progressive Multifocal Leucoencephalopathy (PML) 7/10/2012 9:16:33 AM    More...
Cytheris SA Appoints Damian Marron as Chief Executive Officer 6/12/2012 10:56:54 AM    More...
Cytheris SA Announces Results of Phase II Study Indicating That Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells in Gut Mucosa of Chronically HIV Infected Immunological Non-Responder Patients 3/8/2012 11:55:38 AM    More...
Cytheris SA Announces Interim Results from ECLIPSE 2 Hepatitis C Multicenter Study of IL-7 in Chronically Infected Genotype 1 and 4 Nonresponders to Standard of Care (SOC) 11/8/2011 10:40:45 AM    More...
Cytheris SA Announces Interim Results from ECLIPSE II Hepatitis C Multicenter Study of IL-7 in Chronically Infected Genotype One and Four Nonresponders to Standard of Care (SOC) 11/8/2011 10:13:16 AM    More...
Cytheris SA to Present Interim Data from ECLIPSE 2 Hepatitis C Multicenter Study at AASLD Annual Meeting 10/26/2011 9:29:49 AM    More...
Cytheris SA to Present Interim Data from ECLIPSE 2 Hepatitis C Multicenter Study at AASLD Annual Meeting 10/26/2011 8:43:06 AM    More...
Cytheris SA and Cancer Immunotherapy Trials Network (CITN) Announce Selection of Recombinant Interleukin-7 (CYT107) for Initial Studies at Member Institutions 5/17/2011 9:35:20 AM    More...
12345

//-->